Verastem, Inc. Cost of Revenue
Verastem, Inc. (VSTM) reported Cost of Revenue of $158.00 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2019-05-09
- Verastem, Inc. cost of goods and services sold for the quarter ending 2019-03-31 was $158.00K.
- Verastem, Inc. cost of goods and services sold for the quarter ending 2018-12-31 was $116.00K.
- Verastem, Inc. cost of goods and services sold for the quarter ending 2018-09-30 was $49.00K.
- Verastem, Inc. cost of goods and services sold for fiscal 2018 was $165.00K.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2019-03-31 | $158.00K 10-Q · filed 2019-05-09 | $274.00K derived: sum of 2 quarters · filed 2019-05-09 | $323.00K derived: sum of 3 quarters · filed 2019-05-09 | |
| 2018-12-31 | $116.00K 10-K · filed 2019-03-12 | $165.00K derived: sum of 2 quarters · filed 2019-03-12 | $165.00K 10-K · filed 2019-03-12 | |
| 2018-09-30 | $49.00K 10-K · filed 2019-03-12 | $49.00K 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |